Equity Bancshares (EQBK) Research & Development (2014 - 2026)

Equity Bancshares (EQBK) has reported Research & Development for 13 consecutive years, with $5.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 2.67% year-over-year to $5.2 million in Q2 2026; TTM through Jun 2026 was $20.7 million, a 2.14% increase from a year earlier, with the FY2025 full-year figure at $20.3 million, up 1.37% from the prior year.
• Research & Development was $5.2 million for Q2 2026 at Equity Bancshares, down from $5.4 million in the prior quarter.
• Over five years, Research & Development peaked at $5.4 million in Q1 2026 and troughed at $3.6 million in Q2 2022.
• A 5-year average of $4.7 million and a median of $4.9 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development soared 41.53% in 2022 and fell 5.14% in 2025, its largest moves.
• Over 5 years, Research & Development stood at $4.3 million in 2022, then grew by 3.16% to $4.5 million in 2023, then grew by 11.56% to $5.0 million in 2024, then rose by 5.27% to $5.3 million in 2025, then retreated by 1.16% to $5.2 million in 2026.
• The last three Research & Development figures came in at $5.2 million (Q2 2026), $5.4 million (Q1 2026), and $5.3 million (Q4 2025), per Business Quant data.